I had Vivus on my watchlist to green thumb under 11 ahead of the FDA advisory panel for Qnexa on July 15, and surely enough they dropped a clean point today and slipped under my threshold. Some jitters perhaps? Of the three weight loss drugs vying… More
I'm back at giving them a thumbs down (seems more efficient from a CAPS perspective to 'short' a stock more then once as they are going down). From and earlier post where I gave a thumbs down to this company:Qnexa from Vivus works but there are a… More